AAPS-FIP summary workshop report: Pharmacogenetics in individualized medicine: Methods, regulatory, and clinical applications

AAPS Journal

Volumn 11, Issue 2, 2009, Pages 214-216

  Moridani, Majid ^a   Maitland van der Zee, Anke Hilse ^b   Sasaki, Hitoshi ^c   McKinnon, Ross ^d   Fleckenstein, Lawrence ^e   Shah, Vinod P ^f  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e UNIVERSITY OF IOWA   (United States)

^f FIP   (United States)

Author keywords

Clinical pharmacology; Drug discovery; Drug metabolism; Individualized medicine; Pharmacogenetics; Pharmacogenomics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ABACAVIR; AZATHIOPRINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CODEINE; CYTOCHROME P450 2D6; GENE PRODUCT; GLUCURONOSYLTRANSFERASE 1A1; HLA B ANTIGEN; IRINOTECAN; ISONIAZID; LEPTIN; LEPTIN RECEPTOR; MERCAPTOPURINE; NEUROLEPTIC AGENT; OMEPRAZOLE; PROTEIN VKORC1; SEROTONIN 2C RECEPTOR; TAMOXIFEN; TOLBUTAMIDE; UNCLASSIFIED DRUG; WARFARIN;

CLINICAL PRACTICE; CONFERENCE PAPER; DRUG EFFICACY; DRUG METABOLISM; DRUG RESEARCH; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TRANSPORT; FOOD AND DRUG ADMINISTRATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; INDIVIDUALIZED MEDICINE; MEDICAL EDUCATION; MEDICAL INFORMATION; PHARMACODYNAMICS; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

DRUG THERAPY; HUMANS; LEGISLATION, DRUG; PHARMACOGENETICS; UNITED STATES;

EID: 68249152294     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-009-9097-0     Document Type: Conference Paper

References (0)